ResearcherKyushu UniversityNo recent work listed
Akio Yamasaki
Matched on OpenAlex author ID A5010385392. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 7
- PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. Last author DOI 10.21873/anticanres.15768↗
- TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15205↗
- Hypoxia and pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2020.04.018↗
- Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12122↗
- Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. First author DOI 10.1016/j.canlet.2015.11.012↗
- Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. Co-author PMID 26851020↗
- Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phe… Co-author PMID 27466498↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideya Onishi · 7 shared papers, 2016–2022 · strength 0.73
- Yasuhiro Oyama · 4 shared papers, 2016–2022 · strength 0.40
- Paper PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. DOI 10.21873/anticanres.15768↗
- Paper TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.15205↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Makoto Kawamoto · 4 shared papers, 2016–2017 · strength 0.28
- Paper Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancre… DOI 10.1016/j.canlet.2015.11.012↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Paper Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. PMID 26851020↗
- Akira Imaizumi · 4 shared papers, 2016–2017 · strength 0.28
- Paper Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancre… DOI 10.1016/j.canlet.2015.11.012↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Paper Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. PMID 26851020↗
- Takashi Morisaki · 2 shared papers, 2016–2021 · strength 0.19
- Mitsuo Katano · 2 shared papers, 2016 · strength 0.14
- Paper Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancre… DOI 10.1016/j.canlet.2015.11.012↗
- Paper Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Unde… PMID 27466498↗
- Shinjiro Nagao · 1 shared paper, 2021 · strength 0.12
- Kenichiro Hasumi · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.